The scientists at the Massachusetts Alzheimer’s Disease Research Center are pioneering a unique new gene therapy that could stop the disease in its tracks.
Mass General is leading an important effort to improve care, reduce costs, and increase efficiency with one goal in mind: to improve the patient experience.
Massachusetts General Hospital’s reach extends around the world, where diseases like cancer take a devastating toll. And with cancer mortality rates expected to double by 2030, our work to enhance cancer care in Botswana is critical.
Rose Zaccone was 90 years old when she passed away in 2012. In her estate plan, she directed that Massachusetts General Hospital receive a generous, unrestricted gift. Ms. Zaccone’s bequest to Mass General will ensure that her legacy lives on for generations.
A team of scientists and engineers, led at the Massachusetts General Hospital Diabetes Center by Steven Russell, MD, PhD, have developed and are testing a first-of-its-kind automated device with the potential to revolutionize diabetes treatment. This medical breakthrough is called the bionic pancreas – and it’s closer than ever to making a real world impact on patients.
Linda Keir and her husband Billy were 35,000 feet above the Atlantic on a flight from London to Boston, when Linda suddenly felt a sharp pain in her chest. Within seconds, her right arm and leg turned completely numb.
Fred White has worked at Massachusetts General Hospital for the majority of his life – almost four entire decades.
On a global scale, people are suffering from diseases that can be treated with the help of surgery, such as cancer, trauma, congenital anomalies and obstetric complications. Although many research studies confirm that illnesses treatable by surgical interventions remain a top killer of the world’s most vulnerable populations, surgery has long been a neglected area of global health.
Michael Talkowski, PhD, recipient of the prestigious Martin Prize for Clinical Research, leads a laboratory within the Mass General Center for Human Genetic Research (CHGR).
Dorothy Terrell, a longtime MGH Fund donor, is creating a legacy at Mass General through her involvement as a Board of Trustees member.